These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31977040)

  • 1. Dynamic borrowing in the presence of treatment effect heterogeneity.
    Kotalik A; Vock DM; Donny EC; Hatsukami DK; Koopmeiners JS
    Biostatistics; 2021 Oct; 22(4):789-804. PubMed ID: 31977040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian hierarchical modeling based on multisource exchangeability.
    Kaizer AM; Koopmeiners JS; Hobbs BP
    Biostatistics; 2018 Apr; 19(2):169-184. PubMed ID: 29036300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borrowing from supplemental sources to estimate causal effects from a primary data source.
    Boatman JA; Vock DM; Koopmeiners JS
    Stat Med; 2021 Oct; 40(24):5115-5130. PubMed ID: 34155662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibrated dynamic borrowing using capping priors.
    Ling SX; Hobbs BP; Kaizer AM; Koopmeiners JS
    J Biopharm Stat; 2021 Nov; 31(6):852-867. PubMed ID: 35129422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A group-sequential randomized trial design utilizing supplemental trial data.
    Kotalik A; Vock DM; Hobbs BP; Koopmeiners JS
    Stat Med; 2022 Feb; 41(4):698-718. PubMed ID: 34755388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covariate-adjusted borrowing of historical control data in randomized clinical trials.
    Han B; Zhan J; John Zhong Z; Liu D; Lindborg S
    Pharm Stat; 2017 Jul; 16(4):296-308. PubMed ID: 28560815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian basket trial design with false-discovery rate control.
    Zabor EC; Kane MJ; Roychoudhury S; Nie L; Hobbs BP
    Clin Trials; 2022 Jun; 19(3):297-306. PubMed ID: 35128970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covariate balance for no confounding in the sufficient-cause model.
    Suzuki E; Tsuda T; Yamamoto E
    Ann Epidemiol; 2018 Jan; 28(1):48-53.e2. PubMed ID: 29241736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of relationships between exchangeability, biasing paths and bias.
    Flanders WD; Eldridge RC
    Eur J Epidemiol; 2015 Oct; 30(10):1089-99. PubMed ID: 24894825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust exchangeability designs for early phase clinical trials with multiple strata.
    Neuenschwander B; Wandel S; Roychoudhury S; Bailey S
    Pharm Stat; 2016; 15(2):123-34. PubMed ID: 26685103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Study of Bayesian Information Borrowing Methods in Oncology Clinical Trials.
    Su L; Chen X; Zhang J; Yan F
    JCO Precis Oncol; 2022 Mar; 6():e2100394. PubMed ID: 35263169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional borrowing external data to establish a hybrid control arm in randomized clinical trials.
    Li H; Tiwari R; Li QH
    J Biopharm Stat; 2022 Nov; 32(6):954-968. PubMed ID: 35067183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flexible Bayesian framework for individualized inference via adaptive borrowing.
    Ji Z; Wolfson J
    Biostatistics; 2023 Jul; 24(3):669-685. PubMed ID: 35024790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
    Kaplan D; Chen J; Yavuz S; Lyu W
    Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating historical controls in clinical trials with longitudinal outcomes using the modified power prior.
    Qi H; Rizopoulos D; Lesaffre E; van Rosmalen J
    Pharm Stat; 2022 Sep; 21(5):818-834. PubMed ID: 35128780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covariate handling approaches in combination with dynamic borrowing for hybrid control studies.
    Fu C; Pang H; Zhou S; Zhu J
    Pharm Stat; 2023; 22(4):619-632. PubMed ID: 36882191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
    Quan H; Zhang B; Lan Y; Luo X; Chen X
    Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastic priors to dynamically borrow information from historical data in clinical trials.
    Jiang L; Nie L; Yuan Y
    Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.